Crucially, early viral hepatitis screening plays a vital role in preventing severe liver complications and silent disease progression across India. Currently, experts from AIIMS Delhi highlight that viral hepatitis often progresses without symptoms until advanced damage occurs. Consequently, India bears nearly 12 per cent of the global viral hepatitis burden. Therefore, healthcare providers must promote timely diagnostic testing to protect vulnerable populations.
Importance of Viral Hepatitis Screening
Unquestionably, chronic viral hepatitis remains a silent killer because early infection produces few distinct signs. For example, patients often discover liver injury only after developing jaundice, abdominal swelling, or liver failure. Furthermore, Dr Pramod Garg notes that advanced damage makes clinical management significantly more difficult. Specifically, hepatitis B and C spread through infected blood, unsafe injections, unscreened transfusions, and perinatal transmission. As a result, early testing provides the best window for effective intervention.
Treatment Advances and Public Health Impact
Fortunately, modern medicine offers highly effective strategies to manage chronic viral infections. In fact, standard direct-acting antiviral therapy cures over 95 per cent of hepatitis C patients within three months. Meanwhile, long-term antiviral drugs effectively control chronic hepatitis B virus replication. Additionally, under the National Viral Hepatitis Control Programme, patients can access free diagnostics and treatment. Thus, eliminating structural barriers and social stigma remains essential for expanding diagnostic coverage.
Rising Burden of Metabolic Liver Disease
In addition to viral infections, non-viral factors increasingly contribute to liver morbidity in India. For instance, metabolic dysfunction-associated steatotic liver disease now affects nearly 38 per cent of Indian adults. Moreover, rising rates of childhood obesity and processed food intake cause fatty liver in 35 per cent of children. Consequently, alcohol consumption, viral hepatitis, and fatty liver disease together drive most cases of liver cirrhosis. Therefore, clinicians must adopt holistic preventive approaches, including lifestyle modification, universal newborn vaccination, and routine screening for high-risk groups.
Frequently Asked Questions
Q1: Why is early viral hepatitis screening necessary?
Early screening detects liver inflammation before irreversible damage, such as cirrhosis or liver cancer, develops. Because chronic viral hepatitis usually displays no early symptoms, routine testing helps identify infections early when treatments are most effective.
Q2: How can patients access free hepatitis testing and treatment in India?
Patients can access free diagnostic testing and antiviral medications through the National Viral Hepatitis Control Programme at designated government healthcare centers across the country.
Q3: What lifestyle habits help maintain optimal liver health?
Maintaining a balanced diet, exercising regularly, avoiding alcohol, preventing self-medication with hepatotoxic drugs, ensuring safe drinking water, and completing hepatitis B vaccination significantly protect liver health.
References
- Early screening key to preventing hepatitis deaths: AIIMS experts – ETHealthworld
- National Viral Hepatitis Control Program (NVHCP) – Ministry of Health and Family Welfare, Government of India.
- WHO Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. World Health Organization.
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.